These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9639255)
21. Injections of N-methyl-D-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens. Legault M; Wise RA Synapse; 1999 Mar; 31(4):241-9. PubMed ID: 10051104 [TBL] [Abstract][Full Text] [Related]
22. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway. Crawley JN J Neurosci; 1992 Sep; 12(9):3380-91. PubMed ID: 1527584 [TBL] [Abstract][Full Text] [Related]
23. Levels of CCK immunoreactivity and dopamine in the nucleus accumbens after 6-hydroxydopamine lesions of the ventral tegmental area and the nucleus accumbens. Igarashi Y; Wiegant VM; Van Ree JM Neuropeptides; 1989; 14(2):71-6. PubMed ID: 2812290 [TBL] [Abstract][Full Text] [Related]
24. The neurokinin-3 receptor (NK3R) antagonist SB222200 prevents the apomorphine-evoked surface but not nuclear NK3R redistribution in dopaminergic neurons of the rat ventral tegmental area. Hether S; Misono K; Lessard A Neuroscience; 2013 Sep; 247():12-24. PubMed ID: 23673279 [TBL] [Abstract][Full Text] [Related]
25. Microinjection of cholecystokinin into the rat ventral tegmental area potentiates dopamine-induced hypolocomotion. Crawley JN Synapse; 1989; 3(4):346-55. PubMed ID: 2740993 [TBL] [Abstract][Full Text] [Related]
26. Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Reith ME; Li MY; Yan QS Psychopharmacology (Berl); 1997 Dec; 134(3):309-17. PubMed ID: 9438681 [TBL] [Abstract][Full Text] [Related]
27. Differential involvement of ventral tegmental GABA(A) and GABA(B) receptors in the regulation of the nucleus accumbens dopamine response to stress. Doherty M; Gratton A Brain Res; 2007 May; 1150():62-8. PubMed ID: 17395162 [TBL] [Abstract][Full Text] [Related]
28. Influence of cholecystokinin on central monoaminergic pathways. Widerlöv E; Kalivas PW; Lewis MH; Prange AJ; Breese GR Regul Pept; 1983 May; 6(2):99-109. PubMed ID: 6308717 [TBL] [Abstract][Full Text] [Related]
29. Microinjections of nanogram amounts of sulfated cholecystokinin octapeptide into the rat nucleus accumbens attenuates brain stimulation reward. Vaccarino FJ; Koob GF Neurosci Lett; 1984 Nov; 52(1-2):61-6. PubMed ID: 6098878 [TBL] [Abstract][Full Text] [Related]
30. Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. Blaha CD; Allen LF; Das S; Inglis WL; Latimer MP; Vincent SR; Winn P J Neurosci; 1996 Jan; 16(2):714-22. PubMed ID: 8551354 [TBL] [Abstract][Full Text] [Related]
31. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E Neuropharmacology; 1999 Aug; 38(8):1195-205. PubMed ID: 10462132 [TBL] [Abstract][Full Text] [Related]
32. Reversal by cholecystokinin of apomorphine-induced inhibition of dopamine release in the nucleus accumbens of the rat. Blaha CD; Phillips AG; Lane RF Regul Pept; 1987 Jun; 17(6):301-10. PubMed ID: 3602473 [TBL] [Abstract][Full Text] [Related]
33. D1-D2 dopamine receptor interaction within the nucleus accumbens mediates long-loop negative feedback to the ventral tegmental area (VTA). Rahman S; McBride WJ J Neurochem; 2001 Jun; 77(5):1248-55. PubMed ID: 11389175 [TBL] [Abstract][Full Text] [Related]
34. Effects of long-term haloperidol treatment on the responsiveness of accumbens neurons to cholecystokinin and dopamine: electrophysiological and radioligand binding studies in the rat. Debonnel G; Gaudreau P; Quirion R; de Montigny C J Neurosci; 1990 Feb; 10(2):469-78. PubMed ID: 2137531 [TBL] [Abstract][Full Text] [Related]
36. Microinjection of neuropeptide S into the rat ventral tegmental area induces hyperactivity and increases extracellular levels of dopamine metabolites in the nucleus accumbens shell. Mochizuki T; Kim J; Sasaki K Peptides; 2010 May; 31(5):926-31. PubMed ID: 20156501 [TBL] [Abstract][Full Text] [Related]
37. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study. Blackburn TP; Minabe Y; Middlemiss DN; Shirayama Y; Hashimoto K; Ashby CR Synapse; 2002 Dec; 46(3):129-39. PubMed ID: 12325040 [TBL] [Abstract][Full Text] [Related]
38. Operant responding for optogenetic excitation of LDTg inputs to the VTA requires D1 and D2 dopamine receptor activation in the NAcc. Steidl S; O'Sullivan S; Pilat D; Bubula N; Brown J; Vezina P Behav Brain Res; 2017 Aug; 333():161-170. PubMed ID: 28666837 [TBL] [Abstract][Full Text] [Related]
39. Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation. You ZB; Chen YQ; Wise RA Neuroscience; 2001; 107(4):629-39. PubMed ID: 11720786 [TBL] [Abstract][Full Text] [Related]
40. Overflow of dopamine and cholecystokinin in rat nucleus accumbens in response to acute drug administration. Hamilton ME; Redondo JL; Freeman AS Synapse; 2000 Dec; 38(3):238-42. PubMed ID: 11020226 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]